News

Luna Labs’ MedSim Product Lines Acquired by Integrated Medcraft

Integrated MedCraft LLC today announced it has acquired the TrueClot and Dislotech product lines from Luna Labs. This announcement is more than a successful transaction. It is an example of innovation being accelerated with the right strategic partner.

We built Luna Labs with a clear mission to incubate, accelerate, and grow technologies to the point where they are poised to achieve their full potential. This acquisition demonstrates that our strategy is working as intended.

What started as an SBIR project to create a realistic blood simulant for the Department of Defense has evolved into TrueClot Bleeding Control Training Products. Routinely used to train professional first responders, law enforcement, and combat medics, the market opportunity is bigger than our company can address alone. This acquisition ensures these products will reach the scale and impact they deserve.

Dislotech Joint Reduction Trainers are also ready for growth, offering athletic trainers and medical professionals the opportunity for hands-on joint reduction training prior to practice on patients.

“I am proud of what our Luna Labs’ MedSim team has accomplished,” said Michael Danilich, PhD, Sr. VP of Operations at Luna Labs, and Principal Investigator, TrueClot. “We didn’t just create products, we created new training standards. It’s been rewarding to watch TrueClot grow from a concept to a suite of tools trusted around the world – that’s the kind of impact we strive to achieve.”

This evolution required relentless determination from our development, operations, sales, marketing, and manufacturing teams. They built the most realistic bleeding control and joint reduction training tools available, and their work set a new benchmark for emergency responder training. Congratulations to Brad Day, Kevin Tate, Joe Cattell-Gordon, Ron Wenzel, Keyanna Grayson, Dana Rich, Lianne Landers, Kelley Virgilio, Matt Patterson, Christopher Tison, PhD, MBA, and many others who contributed to this success.

The transition will be seamless with operations, personnel, and manufacturing staying in Charlottesville. TrueClot and Dislotech products will be sold as part of Integrated Medcraft’s full product portfolio and available to emergency response training markets worldwide.

 

Read more here.

Recent News

07/15/2026

Focused Ultrasound Foundation Chairman Receives Lifetime Impact Award

Neal F. Kassell, MD, founder and chairman of the Focused Ultrasound Foundation, received the inaugural Lifetime Impact Award at the 2026 annual meeting of the International Society for Therapeutic Ultrasound (ISTU) in Norway in June. The award honors individuals whose work has fundamentally shaped the development, adoption, and global impact of focused ultrasound. “Dr. Kassell’s

07/14/2026

ARPA-H awards up to $160 million to advance personalized curative medicines for rare genetic diseases

The Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department of Health and Human Services, today announced the teams for the Treating Hereditary Rare Diseases with In Vivo Precision Genetic Medicines (THRIVE) program — a critical investment toward bringing new treatments to patients faster and cure rare genetic pediatric diseases. THRIVE

07/09/2026

Quoin Pharmaceuticals Receives FDA IND Clearance to Initiate Phase 2 Study of QRX003 in Peeling Skin Syndrome

Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application for QRX003 for the treatment of Peeling Skin Syndrome (PSS), enabling initiation of its planned Phase 2 clinical study. Quoin